EN
HI
Summary
As of 15 Nov, 2026, Dipna Pharmachem stock price is ₹4.28. During the trading session, the stock has moved between an intraday low of ₹0.00 and an intraday high of ₹0.00. Over the last 52 weeks, Dipna Pharmachem has traded between ₹3.62 and ₹19.50.
The stock has recorded a trading volume of 0 shares,. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 0 @ ₹4.28.
Dipna Pharmachem has an upper circuit limit of ₹4.70 and a lower circuit limit of ₹3.86. The total value traded stands at ₹0.00, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 3000. Dipna Pharmachem also offers a dividend yield of 0%.
Dipna Pharmachem Share Price Chart
Dipna Pharmachem Share Key Metrics
Volume
0.00
Market Cap
11.54 CR
LTQ@LTP
0@4.28
ATP
0
Var Margin
53.5 %
Circuit Range
3.86-4.7
Delivery %
0 %
Value
0.00
ASM/GSM
No
Market Lot
3000
Dipna Pharmachem Resistance and Support
Pivot 4.32
Resistance
First Resistance
4.36
Second Resistance
4.44
Third Resistance
4.48
Support
First Support
4.24
Second Support
4.2
Third Support
4.12
Dipna Pharmachem Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Nov 13 2026 | 4.39 | 4.39 | 2.57% | 4.39 | 4.39 |
| Thu Nov 12 2026 | 4.4 | 4.28 | 0.47% | 4.4 | 4.28 |
| Wed Nov 11 2026 | 4.15 | 4.26 | 3.15% | 4.26 | 4.15 |
Dipna Pharmachem Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-04 | Quarterly Results |
| 2026-07-02 | Audited Results |
| 2026-07-01 | Audited Results |
| 2025-11-26 | Half Yearly Results |
| 2025-11-19 | Half Yearly Results |
| 2025-11-14 | Half Yearly Results |
| 2025-07-07 | Audited Results |
| 2025-03-12 | Issue Of Warrants & Others |
| 2025-02-24 | Preferential issue of shares |
| 2025-02-06 | Preferential issue of shares |
| 2024-07-29 | Preferential issue & Issue of Warrants |
| 2023-10-11 | Half Yearly Results & Rights issue |
Dipna Pharmachem News
Dipna Pharmachem Ltd - 543594 - Integrated Filing (Finance) For The Quarter Ended On 30Th June, 2026
Dipna Pharmachem announced Q1 FY27 results with revenue at Rs.20.33 crore, up 9.8% YoY. Net profit for the quarter stood at Rs.0.39 crore, marking a 31.5% YoY decline.
Nov 04 2026 17:51:58
Dipna Pharmachem Ltd - 543594 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 4Th November, 2026
Dipna Pharmachem reported its Q1 FY27 standalone financial results, with revenue rising 10% YoY to ₹20.33 crores. However, net profit declined by 31% YoY to ₹0.39 crores. The company also adopted IND AS accounting standards for the first time starting this fiscal year.
Nov 04 2026 17:41:01
Read More
Dipna Pharmachem Management
| Name | Position |
|---|---|
| Keyur Shah | Managing Director & Chief Financial Officer |
| Dipna Shah | Non Executive Director |
Dipna Pharmachem FAQs
The Buying Price of Dipna Pharmachem share is 4.28 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Dipna Pharmachem stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Dipna Pharmachem, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Dipna Pharmachem shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Dipna Pharmachem shares is 0. Useful to assess the stock's value relative to its book value.
To assess Dipna Pharmachem’s valuation compare Sector P/E, P/B which are 46.38 & 1.7 with sector averages, along with growth rates and financial metrics.
The Market Cap of Dipna Pharmachem is 11.54 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Dipna Pharmachem share price is 19.50 & 3.62. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Dipna Pharmachem belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in DPL
